(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
High Cholesterol (Hyperlipidemia)
A 22-week study of a drug designed to decrease "bad" cholesterol and increase "good" cholesterol. Qualified volunteers must be 18 or older, willing to follow the recommended diet and stop taking all lipid-regulating drugs other than the investigational study drug, and meet certain lab results. People with type 1 diabetes mellitus or a history of diabetic ketoacidosis, or uncontrolled type 2 diabetes mellitus are not eligible.
Research sites are located throughout the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat170.html.
-----
Pregnancy Complications
This is a clinical research study for pregnant women ages 18-45 who are at high risk of spontaneous preterm delivery. Women must be between 16-22 weeks of pregnancy at the time of the first screening visit. Participants will be followed every two weeks by a study-assigned OB/GYN. An ultrasound for cervical length measurement will be performed prior to participating, and also at 28 weeks of pregnancy.
Research sites are located across the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat650.html.
-----
Migraine and Cluster Headaches
This research study will evaluate a study drug designed to prevent episodic migraines from developing into chronic daily headache (head pain that occurs at least 15 days per month). Candidates 18-65 with a history of migraines may be eligible for the study, which will last approximately 10 months.
Research sites are located throughout the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat100.html.
-----
Copyright 2006 CenterWatch. All rights reserved.
